BEUDAMED
    101 results · 21ms · Sources: EU EUDAMED, US FDA
    Filters Classification: FDA Class 3 ×

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT ENDOPROSTHESIS

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·Wallstent™ Venous Endoprosthesis with Unistep Plus™ Delivery System

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·Wallstent (Venous) Endoprosthesis With Unistep Plus Delivery System

    Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

    FDA Pre-Market Approval
    FDA Class 3 ·VENTANA MMR RxDx Panel

    Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

    FDA Pre-Market Approval
    FDA Class 3 ·VENTANA MMR RxDx Panel (Endometrial Cancer with dMMR status)

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT (TIPS, ILIAC, VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

    Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

    FDA Pre-Market Approval
    FDA Class 3 ·VENTANA MMR RxDx Panel (Endometrial Cancer with dMMR status)

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM (VENOUS)

    Immunocytochemistry Assay, P16/Ki-67

    FDA Pre-Market Approval
    FDA Class 3 ·CINtec PLUS Cytology

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT ENDOPROSTHESIS

    Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

    FDA Pre-Market Approval
    FDA Class 3 ·VENTANA MMR RxDx Panel Solid Tumors with dMMR status)

    Immunocytochemistry Assay, P16/Ki-67

    FDA Pre-Market Approval
    FDA Class 3 ·CINtec PLUS Cytology

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT SYSTEM (10 MM VENOUS ENDOPROSTHESIS) AND UNISTEP PLUS DELIVERY SYSTEM (12 MM VENOUS ENDOPROSTHESIS)

    Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

    FDA Pre-Market Approval
    FDA Class 3 ·VENTANA MMR RxDx Panel (Solid Tumors with dMMR status)

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT (VENOUS) ENDOPROSTHESIS

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·Wallstent (Venous) Endoprosthesis With Unistep Plus Delivery System

    Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

    FDA Pre-Market Approval
    FDA Class 3 ·VENTANA MMR RxDx Panel (Endometrial Cancer with dMMR status)

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT (ILIAC, TIPS, VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM